Cargando…
Clickable Shiga Toxin B Subunit for Drug Delivery in Cancer Therapy
[Image: see text] In recent years, receptor-mediated drug delivery has gained major attention in the treatment of cancer. The pathogen-derived Shiga Toxin B subunit (STxB) can be used as a carrier that detects the tumor-associated glycosphingolipid globotriaosylceramide (Gb3) receptors. While drug c...
Autores principales: | Danielewicz, Natalia, Rosato, Francesca, Tomisch, Jana, Gräber, Jonas, Wiltschi, Birgit, Striedner, Gerald, Römer, Winfried, Mairhofer, Juergen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157870/ https://www.ncbi.nlm.nih.gov/pubmed/37151527 http://dx.doi.org/10.1021/acsomega.3c00667 |
Ejemplares similares
-
In-Depth Characterization of a Re-Engineered Cholera Toxin Manufacturing Process Using Growth-Decoupled Production in Escherichia coli
por: Danielewicz, Natalia, et al.
Publicado: (2022) -
A Shiga Toxin B-Subunit-Based Lectibody Boosts T Cell Cytotoxicity towards Gb3-Positive Cancer Cells
por: Tomisch, Jana, et al.
Publicado: (2023) -
A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death
por: Rosato, Francesca, et al.
Publicado: (2022) -
Do the A Subunits Contribute to the Differences in the Toxicity of Shiga Toxin 1 and Shiga Toxin 2?
por: Basu, Debaleena, et al.
Publicado: (2015) -
Protein Kinase Signaling by Shiga Toxin Subunits
por: Oloomi, Mana, et al.
Publicado: (2021)